[New bone density conservation agents for osteoporosis under research and development: ED-71].
Hagino
Hiroshi
H
Rehabilitation Division, Tottori University Hospital.
D000818:Animals; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001842:Bone and Bones / Q000378:metabolism / Q000503:physiopathology; D002117:Calcitriol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015195:Drug Design; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D010012:Osteogenesis / Q000187:drug effects; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D013718:Tensile Strength / Q000187:drug effects; D014807:Vitamin D / Q000031:analogs & derivatives
D050071:Bone Density Conservation Agents; D014807:Vitamin D; D002117:Calcitriol; C547512:eldecalcitol